These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22959966)

  • 61. Nomifensine reveals age-related changes in K(+)-evoked striatal DA overflow in F344 rats.
    Stanford JA; Currier TD; Purdom MS; Gerhardt GA
    Neurobiol Aging; 2001; 22(3):495-502. PubMed ID: 11378257
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ethanol potentiates dopamine release during acute hypoxia in rat striatum.
    Wang Y; Chiou AL; Jeng CH; Yang ST; Lin JC
    Pharmacol Biochem Behav; 2000 Aug; 66(4):679-85. PubMed ID: 10973503
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats.
    You ZB; Herrera-Marschitz M; Nylander I; Goiny M; Kehr J; Ungerstedt U; Terenius L
    Brain Res; 1996 Feb; 710(1-2):241-8. PubMed ID: 8963665
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Opposite effects of sulpiride and SCH 23390 on ethanol-induced striatal ascorbic acid release in intact and 6-hydroxydopamine lesioned rats.
    Liu W; Wu CF; Huang M; Xiao K
    Brain Res; 2000 Jun; 869(1-2):31-8. PubMed ID: 10865056
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of locally infused 2-chloroadenosine, an A1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum.
    Ballarin M; Reiriz J; Ambrosio S; Mahy N
    Neurosci Lett; 1995 Feb; 185(1):29-32. PubMed ID: 7731548
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does monoamine oxidase inhibition by pargyline increase extracellular dopamine concentrations in the striatum?
    Blaha CD; Coury A; Phillips AG
    Neuroscience; 1996 Nov; 75(2):543-50. PubMed ID: 8931017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo.
    Moison D; De Deurwaerdère P; Cagnotto A; Marrazzo A; Prezzavento O; Ronsisvalle G; Mennini T; Spampinato U
    Neuropharmacology; 2003 Dec; 45(7):945-53. PubMed ID: 14573387
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of ascorbate in microdialysis perfusion medium on the extracellular basal concentration of glutamate in rat's striatum.
    Lai YJ; Shen EY; Pan WH
    Neurosci Lett; 2000 Feb; 279(3):145-8. PubMed ID: 10688050
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A cholinergic input to the substantia nigra pars compacta increases striatal dopamine metabolism measured by in vivo voltammetry.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Aceves J
    Brain Res; 1992 Dec; 598(1-2):114-20. PubMed ID: 1486473
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum.
    Harsing LG; Sershen H; Lajtha A
    J Neural Transm Gen Sect; 1994; 96(3):215-25. PubMed ID: 7826572
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ketamine antagonizes hypoxia-induced dopamine release in rat striatum.
    Wang Y; Chiou AL; Yang ST; Lin JC
    Brain Res; 1995 Sep; 693(1-2):233-45. PubMed ID: 8653414
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism.
    Mizoguchi K; Yokoo H; Yoshida M; Tanaka T; Tanaka M
    Brain Res; 1994 Oct; 662(1-2):255-8. PubMed ID: 7859080
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Involvement of dopamine signaling in the circadian modulation of interval timing.
    Bussi IL; Levín G; Golombek DA; Agostino PV
    Eur J Neurosci; 2014 Jul; 40(1):2299-310. PubMed ID: 24689904
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neurochemical effects of prolonged treatment with remoxipride as assessed by intracerebral microdialysis in freely moving rats.
    Georgieva J; Mohringe B; Magnusson O
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1187-201. PubMed ID: 7846288
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum.
    Kerkerian-Le Goff L; Forni C; Samuel D; Bloc A; Dusticier N; Nieoullon A
    Brain Res Bull; 1992 Feb; 28(2):187-93. PubMed ID: 1596740
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum.
    Tata DA; Yamamoto BK
    Synapse; 2008 May; 62(5):325-36. PubMed ID: 18288648
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Post-mortem dopamine dynamics assessed by voltammetry and microdialysis.
    Gonzalez-Mora JL; Maidment NT; Guadalupe T; Mas M
    Brain Res Bull; 1989; 23(4-5):323-7. PubMed ID: 2590845
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of successive intrastriatal methylmercury administrations on dopaminergic system.
    Faro LR; Durán R; Do Nascimento JL; Perez-Vences D; Alfonso M
    Ecotoxicol Environ Saf; 2003 Jun; 55(2):173-7. PubMed ID: 12742365
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Direct in vivo electrochemical monitoring of dopamine release in response to neuroleptic drugs.
    Blaha CD; Lane RF
    Eur J Pharmacol; 1984 Feb; 98(1):113-7. PubMed ID: 6143672
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of dopamine depletion on the H2O2 production in the rat striatum following transient middle cerebral artery occlusion.
    Lei B; Adachi N; Nagaro T; Arai T
    Brain Res; 1997 Aug; 764(1-2):299-302. PubMed ID: 9295229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.